CD40L Recombinant Antibody, RBITC Conjugated
Product Specifications
Background
Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL-4. Involved in immunoglobulin class switching. Release of soluble CD40L from platelets is partially regulated by GP IIb/IIIa, actin polymerization, and an matrix metalloproteinases (MMP) inhibitor-sensitive pathway.
Synonyms
CD40 ligand; CD40-L; T-cell antigen Gp39; TNF-related activation protein; TRAP; CD154; CD40 ligand, membrane form; CD40 ligand, soluble form; CD40LG; CD40L; TNFSF5; TRAP.
Gene ID
959
Swiss Prot
P29965
Cellular Locus
Secreted, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse
Target
CD40L
Clonality
Recombinant
Isotype
IgG
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human CD40L
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
959
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP96867 50 µg
Recombinant Bacillus licheniformis BliGO/thiO Protein, N-GST & C-His
Sign In for Pricing
View Details